1. Home
  2. OLB vs PMCB Comparison

OLB vs PMCB Comparison

Compare OLB & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The OLB Group Inc.

OLB

The OLB Group Inc.

HOLD

Current Price

$0.43

Market Cap

7.7M

Sector

Technology

ML Signal

HOLD

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.69

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLB
PMCB
Founded
1993
1996
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
8.3M
IPO Year
2019
2001

Fundamental Metrics

Financial Performance
Metric
OLB
PMCB
Price
$0.43
$0.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
351.4K
147.8K
Earning Date
05-14-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
71.48
277.22
EPS
N/A
N/A
Revenue
$8,676,907.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.63
52 Week High
$2.50
$1.51

Technical Indicators

Market Signals
Indicator
OLB
PMCB
Relative Strength Index (RSI) 37.90 46.73
Support Level $0.31 $0.65
Resistance Level $0.58 $0.80
Average True Range (ATR) 0.06 0.07
MACD -0.01 -0.00
Stochastic Oscillator 24.77 29.10

Price Performance

Historical Comparison
OLB
PMCB

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Share on Social Networks: